US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 55.390
  • -1.800-3.15%
Close Jul 24 16:00 ET
  • 55.390
  • 0.0000.00%
Post 16:47 ET
4.70BMarket Cap-20514P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

504.00K

-99.50%
EPS(YoY)

-1.43

-113.43%
Analyst Rating

Buy

Jul 24, 2024

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.849M--
--2024/Q2-- / 13.613M--
--2024/Q1504.000K / 26.494M--
--2023/Q4201.206M / 123.085M--
--2023/Q30.000 / 7.956M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.849M--
--2024/Q2-- / 13.613M--
--2024/Q1504.000K / 26.494M--
--2023/Q4201.206M / 123.085M--
--2023/Q30.000 / 7.956M--

Unlock Free Earnings Estimates

CRISPR Therapeutics Earnings Reports

  • CRISPR Therapeutics | 10-Q: Quarterly report

    May 8 16:29 ET

  • CRISPR Therapeutics | 10-K: Annual report

    Feb 21 07:55 ET

  • CRISPR Therapeutics: Q3 2023 Earnings Report

    Nov 6, 2023 16:42 ET

  • CRISPR Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 24, 2024

    Buy

    • Buy

      56.25%

    • Hold

      31.25%

    • Sell

      12.50%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.51%
    ARK Holdings
    ARK Holdings
    Intraday-10.23%